title: The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension.
abstract: A polymorphism at position 825 (C-->T) of the cDNA that encodes the beta3 subunit (GNB3) of the pertussis toxin-sensitive G protein was recently shown to be associated with human hypertension. To verify this finding and to investigate whether this polymorphism could also be associated with coronary heart disease, we analyzed the GNB3 variant in subjects from 2 previously described studies: Projet d'Etude des Gènes de l'hypertension Artérielle Sévère à modérée Essentielle (PEGASE), a case-control study of moderate to severe hypertension (681 cases and 308 controls), and Etude Cas-Témoins de l'Infarctus du Myocarde (ECTIM), a case-control study of myocardial infarction (MI) (564 cases and 633 controls). Genotyping was performed with allele-specific oligonucleotides. Genotype and allele frequencies were in Hardy-Weinberg equilibrium in all groups. Allele and genotype frequencies did not differ significantly between case patients with essential hypertension or MI and control subjects. In the ECTIM study, the 825T allele frequencies in cases and controls from Belfast, Northern Ireland, were 0.31 and 0.30 (P=0.79), respectively; the corresponding frequencies in cases and controls from France were 0.33 and 0.31 (P=0.30), respectively. In the PEGASE study, the 825T allele frequency was 0.35 in female and male cases and 0.31 in male normotensive controls (P=0.12). The odds ratios for hypertension (PEGASE) and MI (ECTIM) associated with T-allele carrying were 1.23 (95% confidence interval, 0.94 to 1.62; P=0.13) and 1.11 (95% confidence interval, 0.88 to 1.39; P=0.37), respectively. There was no association of the GNB3 polymorphism with early onset of hypertension, familial history of hypertension, or blood pressure level. We conclude that the 825C/T polymorphism of the GNB3 gene did not contribute in any important way to the risk of essential hypertension or MI in these studies.
authors.affiliation: Institut National de la Santè et de la Recherche Médicale (INSERM) U525, 17 rue du Fer à Moulin, 75005 Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Brand
authors.forename: S M
authors.initials: SM
authors.lastname: Herrmann
authors.forename: V
authors.initials: V
authors.lastname: Nicaud
authors.forename: J B
authors.initials: JB
authors.lastname: Ruidavets
authors.forename: A
authors.initials: A
authors.lastname: Evans
authors.forename: D
authors.initials: D
authors.lastname: Arveiler
authors.forename: G
authors.initials: G
authors.lastname: Luc
authors.forename: P F
authors.initials: PF
authors.lastname: Plouin
authors.forename: L
authors.initials: L
authors.lastname: Tiret
authors.forename: F
authors.initials: F
authors.lastname: Cambien
mesh_terms: D000328:Adult; D000483:Alleles; D015992:Body Mass Index; D016022:Case-Control Studies; D016001:Confidence Intervals; D003327:Coronary Disease / Q000235:genetics; D018076:DNA, Complementary / Q000235:genetics*; D003627:Data Interpretation, Statistical; D005260:Female; D019204:GTP-Binding Proteins / Q000235:genetics*; D005796:Genes / Q000235:genetics; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000235:genetics; D011110:Polymorphism, Genetic
chemical_list: D018076:DNA, Complementary; D019204:GTP-Binding Proteins